Skip to main content
. 2021 Jun 25;14(5):1689–1704. doi: 10.1111/cts.13061

TABLE 2.

Classification of renal function based on FDA and EMA guidances 8 , 9

Stage Description Renal function a , b (ml/min) GFR d (ml/min)
1 Control (normal renal function)7 ≥90 ≥90
2 Mild 60–89 60 to <90
3 Moderate 30–59 30 to <60
4 Severe 15–29 <30 (dialysis not required)
5 Kidney failure a , c ; ESRD d <15 or dialysis patients on non‐dialysis days <15 requiring dialysis

Abbreviations: EMA, European Medicines Agency; ESRD, end‐stage renal disease; FDA, US Food and Drug Administration; GFR, glomerular filtration rate.

a

As stated in the FDA guidance.

b

Estimate of GFR based on an estimation equation and expressed in ml/min. To convert ml/min/1.73 m2 to ml/min multiply by the individual’s body surface area calculated using an appropriate formula and divide by 1.73.

c

This classification is strictly for the purposes of conducting a dedicated renal impairment study and should not be used for the purposes of classifying kidney disease.

d

As stated in the EMA guidance.